Global Cutaneous Leishmaniasis Drugs Market Comprehensive Insight by Growth Rate, Industry Status, Forecast till 2027
The global cutaneous leishmaniasis drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Cutaneous leishmaniasis spreads by the bite of sandflies and primarily affects the skin. Its drugs are generally effective and work well against the parasites causing leishmaniasis. The major factors that are driving the growth of the global cutaneous leishmaniasis drugs market include the growing prevalence of parasitic infections among the global population, ease of direct purchase due to the access to OTC drugs, and the constant innovations and developments of drugs. The prevalence of leishmaniasis is highly subject to environmental factors coupled with natural conditions. Areas with rich vegetation and climatic factors are majorly responsible for the spread of sandflies and the subsequent outbreak of leishmaniasis. For instance, as per the World Health Organization (WHO), it is anticipated that between 600,000 to 1.0 million new global cases of leishmaniasis occur yearly.
To Request a Sample of our Report on Global Cutaneous
Leishmaniasis Drugs Market: https://www.omrglobal.com/request-sample/cutaneous-leishmaniasis-drugs-market
The approved drugs for cutaneous leishmaniasis treatment are majorly
fluconazole, impavido, pentam 300 solution, diflucan tablet azole
antifungals-systemic, miltefosine capsule, and pentamidine 300 mg solution for
injection antiprotozoal agents. However, cutaneous leishmaniasis can be
prevented with the support of prophylactic vaccines. The development and
consumption of such vaccines support in controlling the disease. Thus, such
development is expected to have a positive impact on the overall market growth.
Market Coverage
·
The market number available for – 2020-2027
·
Base year- 2020
·
Forecast period- 2021-2027
·
Segment Covered
·
Regions Covered- Globally
·
Competitive Landscape: GlaxoSmithKline plc,
Pfizer Inc., and Novartis International AG, among others.
(Get 15% Discount on Buying this Report)
A
full Report of Global Cutaneous Leishmaniasis Drugs Market is Available
at: https://www.omrglobal.com/industry-reports/cutaneous-leishmaniasis-drugs-market
Global Cutaneous Leishmaniasis Drugs Market Report by Segment
By Type
• Pentavalent
Antimonials
• Antifungal Drugs
• Anti-Leishmanial/Antimicrobial
Drugs
By Distribution Channel
• Hospital
Pharmacies
• Retail Pharmacies
• Online Pharmacies
Global Cutaneous Leishmaniasis Drugs Market by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other research-based
services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment